149 related articles for article (PubMed ID: 38306770)
1. A Step Toward the Development of the First National Multi-Criteria Decision Analysis Framework to Support Healthcare Decision Making in Saudi Arabia.
Al-Jedai A; Almudaiheem H; Alruthia Y; Althemery A; Alabdulkarim H; Ojeil R; Alrumaih A; AlGhannam S; AlMutairi A; Hasnan Z
Value Health Reg Issues; 2024 May; 41():100-107. PubMed ID: 38306770
[TBL] [Abstract][Full Text] [Related]
2. Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut).
Guarga L; Badia X; Obach M; Fontanet M; Prat A; Vallano A; Torrent J; Pontes C
Orphanet J Rare Dis; 2019 Jun; 14(1):157. PubMed ID: 31248421
[TBL] [Abstract][Full Text] [Related]
3. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
4. International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review.
Lasalvia P; Prieto-Pinto L; Moreno M; Castrillón J; Romano G; Garzón-Orjuela N; Rosselli D
Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):409-420. PubMed ID: 31210065
[No Abstract] [Full Text] [Related]
5. Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs.
Kolasa K; Zwolinski KM; Kalo Z; Hermanowski T
Orphanet J Rare Dis; 2016 Mar; 11():23. PubMed ID: 26965710
[TBL] [Abstract][Full Text] [Related]
6. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
Tony M; Wagner M; Khoury H; Rindress D; Papastavros T; Oh P; Goetghebeur MM
BMC Health Serv Res; 2011 Nov; 11():329. PubMed ID: 22129247
[TBL] [Abstract][Full Text] [Related]
7. DRUG EVALUATION AND DECISION MAKING IN CATALONIA: DEVELOPMENT AND VALIDATION OF A METHODOLOGICAL FRAMEWORK BASED ON MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR ORPHAN DRUGS.
Gilabert-Perramon A; Torrent-Farnell J; Catalan A; Prat A; Fontanet M; Puig-Peiró R; Merino-Montero S; Khoury H; Goetghebeur MM; Badia X
Int J Technol Assess Health Care; 2017 Jan; 33(1):111-120. PubMed ID: 28434413
[TBL] [Abstract][Full Text] [Related]
8. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
9. A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study).
de Andrés-Nogales F; Cruz E; Calleja MÁ; Delgado O; Gorgas MQ; Espín J; Mestre-Ferrándiz J; Palau F; Ancochea A; Arce R; Domínguez-Hernández R; Casado MÁ;
Orphanet J Rare Dis; 2021 Apr; 16(1):186. PubMed ID: 33902672
[TBL] [Abstract][Full Text] [Related]
10. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
[TBL] [Abstract][Full Text] [Related]
11. Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs.
Schey C; Krabbe PF; Postma MJ; Connolly MP
Orphanet J Rare Dis; 2017 Jan; 12(1):10. PubMed ID: 28095876
[TBL] [Abstract][Full Text] [Related]
12. Multicriteria decision analysis in health care decision in oncology: a systematic review.
Campolina AG; Suzumura EA; Hong QN; de Soárez PC
Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):365-380. PubMed ID: 34913775
[TBL] [Abstract][Full Text] [Related]
13. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
[TBL] [Abstract][Full Text] [Related]
14. Value-based decision-making for orphan drugs with multiple criteria decision analysis: burosumab for the treatment of X-linked hypophosphatemia.
Vandewalle B; Amorim M; Ramos D; Azevedo S; Alves I; Francisco T; Pinto H; Sousa S
Curr Med Res Opin; 2021 Jun; 37(6):1021-1030. PubMed ID: 33733971
[TBL] [Abstract][Full Text] [Related]
15. Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.
Mühlbacher AC; Kaczynski A
Appl Health Econ Health Policy; 2016 Feb; 14(1):29-40. PubMed ID: 26519081
[TBL] [Abstract][Full Text] [Related]
16. Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology.
Badia X; Aguarón A; Fernández A; Gimón A; Nafria B; Gaspar B; Guarga L; Gálvez M; Fuentes M; Paco N; Saldaña R
Int J Technol Assess Health Care; 2019 Jan; 35(1):56-63. PubMed ID: 30730288
[TBL] [Abstract][Full Text] [Related]
17. Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs-a Systematic Literature Review. Next Steps in Methodology Development?
Baran-Kooiker A; Czech M; Kooiker C
Front Public Health; 2018; 6():287. PubMed ID: 30374435
[No Abstract] [Full Text] [Related]
18. Multiple Criteria Decision Analysis (MCDA) for evaluating cancer treatments in hospital-based health technology assessment: The Paraconsistent Value Framework.
Campolina AG; Estevez-Diz MDP; Abe JM; de Soárez PC
PLoS One; 2022; 17(5):e0268584. PubMed ID: 35613115
[TBL] [Abstract][Full Text] [Related]
19. Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis.
Kolasa K; Zwolinski KM; Zah V; Kaló Z; Lewandowski T
Orphanet J Rare Dis; 2018 Apr; 13(1):67. PubMed ID: 29703227
[TBL] [Abstract][Full Text] [Related]
20. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward.
Baltussen R; Marsh K; Thokala P; Diaby V; Castro H; Cleemput I; Garau M; Iskrov G; Olyaeemanesh A; Mirelman A; Mobinizadeh M; Morton A; Tringali M; van Til J; Valentim J; Wagner M; Youngkong S; Zah V; Toll A; Jansen M; Bijlmakers L; Oortwijn W; Broekhuizen H
Value Health; 2019 Nov; 22(11):1283-1288. PubMed ID: 31708065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
